DANA MAYS: Open Payments
NPI 1831370154 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$238 in 11 payments from 5 companies in 2025. Trend: 2023 $843 · 2024 $1,102 · 2025 $238
Food & beverage: $238
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 5 | $96 |
| ViiV Healthcare Company | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| ABBVIE INC. | 1 | $23 |
Products named: REXULTI, PIFELTRO, DOVATO, CABENUVA, VRAYLAR.
Industry payments across LA — which companies pay providers there.
